Molecular landscape and targeted therapy of acute myeloid leukemia
Abstract For decades, genetic aberrations including chromosome and molecular abnormalities are important diagnostic and prognostic factors in acute myeloid leukemia (AML). ATRA and imatinib have been successfully used in AML and chronic myelogenous leukemia, which proved that targeted therapy by ide...
Saved in:
Main Authors: | Runxia Gu (Author), Xue Yang (Author), Hui Wei (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Targeting and Rational Chemotherapy in Acute Myeloid Leukemia
by: Pourrajab F, et al.
Published: (2020) -
Advances in targeted therapy for acute myeloid leukemia
by: Jifeng Yu, et al.
Published: (2020) -
Epigenetic modifications and targeted therapy in pediatric acute myeloid leukemia
by: Huan Xu, et al.
Published: (2022) -
Targeting Approaches of Nanomedicines in Acute Myeloid Leukemia
by: Xiao Huang, et al.
Published: (2019) -
Progress in RNAi-mediated Molecular Therapy of Acute and Chronic Myeloid Leukemia
by: Breanne Landry, et al.
Published: (2015)